Moomoo AI 已提取核心信息
TC BioPharm (Holdings) PLC, a biopharmaceutical company, has announced a General Meeting (GM) of shareholders to be held on March 14, 2024. The meeting will take place at 2:00 p.m. UK time at the company's registered office in Holytown, Motherwell. The GM will address two ordinary resolutions: the authorization to adjourn the meeting if necessary to solicit further proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which is crucial for the company's operations and business strategy implementation. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with...Show More
TC BioPharm (Holdings) PLC, a biopharmaceutical company, has announced a General Meeting (GM) of shareholders to be held on March 14, 2024. The meeting will take place at 2:00 p.m. UK time at the company's registered office in Holytown, Motherwell. The GM will address two ordinary resolutions: the authorization to adjourn the meeting if necessary to solicit further proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which is crucial for the company's operations and business strategy implementation. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and the company has provided detailed instructions for voting, including for holders of American Depositary Shares (ADSs). The GM documentation and voting instruction cards will be distributed accordingly, with a deadline for ADS voting instructions set for March 8, 2024. The company's CEO, Bryan Kobel, has expressed gratitude for the ongoing support and highlighted the importance of the resolutions for the company's future success.
生物制药公司TC Biopharm（Holdings）PLC宣布将于2024年3月14日举行股东大会（GM）。会议将于英国时间下午 2:00 在该公司位于马瑟韦尔霍利敦的注册办事处举行。总经理将讨论两项普通决议：授权在必要时休会以征集更多代理人，以及授权根据纳斯达克市场规则5635（d）在一次或多次非公开发行中发行证券。后者是一项战略举措，旨在筹集高达400万美元的额外资金，这对于公司的运营和业务战略的实施至关重要。董事会一致建议股东对这些决议投赞成票，强调这些决议符合公司的最大利益。在2024年3月12日之前注册的股东有权投票，该公司已提供了详细的投票说明，包括针对美国存托股份（ADS）持有人的投票说明。通用汽车文件和投票说明卡将相应分发，ADS投票说明的截止日期定为2024年3月8日。该公司首席执行官布莱恩·科贝尔对持续的支持表示感谢，并强调了这些决议对公司未来成功的重要性。
生物制药公司TC Biopharm（Holdings）PLC宣布将于2024年3月14日举行股东大会（GM）。会议将于英国时间下午 2:00 在该公司位于马瑟韦尔霍利敦的注册办事处举行。总经理将讨论两项普通决议：授权在必要时休会以征集更多代理人，以及授权根据纳斯达克市场规则5635（d）在一次或多次非公开发行中发行证券。后者是一项战略举措，旨在筹集高达400万美元的额外资金，这对于公司的运营和业务战略的实施至关重要。董事会一致建议股东对这些决议投赞成票，强调这些决议符合公司的最大利益。在2024年3月12日之前注册的股东有权投票，该公司已提供了详细的投票说明，包括针对美国存托股份（ADS）持有人的投票说明。通用汽车文件和投票说明卡将相应分发，ADS投票说明的截止日期定为2024年3月8日。该公司首席执行官布莱恩·科贝尔对持续的支持表示感谢，并强调了这些决议对公司未来成功的重要性。
有用
没用